NetEase (NTES) Q2 2026 Earnings Call Transcript

Business & Economy

What to know

  • Gaming revenue surged 10% as new titles and AI tools expanded margins.S1
  • Revenue hit $14.9 million with 29% growth; backlog reached $31 million.S2
  • Revenue surged 32.4% as 1P business and refurbished devices drove growth.S3
  • Record trading volumes and client assets surge as U.S. tech demand accelerates.S4
  • OSI Systems, Inc. (OSIS) Q4 2026 Earnings Call TranscriptS5
  • Vext Science Inc. (VEXTF) Q2 2026 Earnings Call TranscriptS6
  • Revenue surged 561% year-over-year to $46.1 million following the Juniper merger.S7
  • Net loss narrowed to $6.3 million as operating costs fell and FDA submissions advanced.S8
Timeline · newest first
2mos Fool

NetEase (NTES) Q2 2026 Earnings Call Transcript

Gaming revenue surged 10% as new titles and AI tools expanded margins.

2mos Fool

B.O.S. (BOSC) Q2 2026 Earnings Call Transcript

Revenue hit $14.9 million with 29% growth; backlog reached $31 million.

2mos Fool

ATRenew (RERE) Q2 2026 Earnings Call Transcript

Revenue surged 32.4% as 1P business and refurbished devices drove growth.

2mos Fool

Futu (FUTU) Q2 2026 Earnings Call Transcript

Record trading volumes and client assets surge as U.S. tech demand accelerates.

2mos Fool

PEDEVCO (PED) Q2 2026 Earnings Call Transcript

Revenue surged 561% year-over-year to $46.1 million following the Juniper merger.

2mos Fool

Co-Dx (CODX) Q2 2026 Earnings Call Transcript

Net loss narrowed to $6.3 million as operating costs fell and FDA submissions advanced.

2mos Fool

Blaize (BZAI) Q2 2026 Earnings Call Transcript

Revenue guidance cut to $40 million–$43 million as memory costs rise and customer timelines extend.

2mos Fool

Caliber (CWD) Q2 2026 Earnings Call Transcript

Tokenization and debt refinancing reshape capital formation strategy.

2mos Fool

Veritone (VERI) Q2 2026 Earnings Call Transcript

VDR revenue surged 71% as management targets breakeven by mid-2027.

2mos Fool

Afya (AFYA) Q2 2026 Earnings Call Transcript

Medical education revenue grew 7% amid AI competition in clinical tools.

2mos Fool

AudioEye (AEYE) Q2 2026 Earnings Call Transcript

Revenue hit $10.7 million with 42 straight quarters of growth; EBITDA guidance was raised.

2mos Fool

Nektar (NKTR) Q2 2026 Earnings Call Transcript

Phase 3 trials for rezpegaldesleukin advance in atopic dermatitis and alopecia areata.

2mos Fool

StoneCo (STNE) Q2 2026 Earnings Call Transcript

Credit portfolio doubled as management navigates higher rates and defaults.

2mos Fool

Nu (NU) Q2 2026 Earnings Call Transcript

Net income hit $1.1 billion while customer base grew to 139 million.

2mos Fool

Volition (VNRX) Q2 2026 Earnings Call Transcript

Revenue flat as cost cuts narrowed losses and cash strengthened.

2mos Fool

Eton Pharmaceuticals (ETON) Q2 2026 Earnings Call Transcript

Revenue surged 99% year-over-year on HEMANGEOL relaunch and rare disease portfolio growth.

2mos Fool

Tenon Medical (TNON) Q2 2026 Earnings Call Transcript

Record revenue and gross profit driven by surgical volume and system integration.

NetEase (NTES) Q2 2026 Earnings Call Transcript

3 outlets 25 reports

What to know

  • Gaming revenue surged 10% as new titles and AI tools expanded margins.S1
  • Revenue hit $14.9 million with 29% growth; backlog reached $31 million.S2
  • Revenue surged 32.4% as 1P business and refurbished devices drove growth.S3
  • Record trading volumes and client assets surge as U.S. tech demand accelerates.S4
  • OSI Systems, Inc. (OSIS) Q4 2026 Earnings Call TranscriptS5
  • Vext Science Inc. (VEXTF) Q2 2026 Earnings Call TranscriptS6
  • Revenue surged 561% year-over-year to $46.1 million following the Juniper merger.S7
  • Net loss narrowed to $6.3 million as operating costs fell and FDA submissions advanced.S8
Timeline · newest first

Sources · 8 citations

S1S2S3S4S7S8 FoolLead 17 reports · EN
S5S6 Seekingalpha 5 reports · EN
Yahoo Finance 3 reports · EN